Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus.

Studnicka-Benke A, Steiner G, Petera P, Smolen JS.

Br J Rheumatol. 1996 Nov;35(11):1067-74.

PMID:
8948291
2.

Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.

Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC.

Clin Rheumatol. 1999;18(1):17-22.

PMID:
10088943
3.

Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?

Gómez D, Correa PA, Gómez LM, Cadena J, Molina JF, Anaya JM.

Semin Arthritis Rheum. 2004 Jun;33(6):404-13.

PMID:
15190525
4.

Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis.

Sabry A, Elbasyouni SR, Sheashaa HA, Alhusseini AA, Mahmoud K, George SK, Kaleek EA, abo-Zena H, Kalil AM, Mohsen T, Rahim MA, El-samanody AZ.

Int Urol Nephrol. 2006;38(3-4):731-7. Epub 2007 Jan 27.

PMID:
17260180
5.

Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.

Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA.

J Rheumatol. 1997 Feb;24(2):303-8.

PMID:
9034987
7.

Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.

Sabry A, Sheashaa H, El-Husseini A, Mahmoud K, Eldahshan KF, George SK, Abdel-Khalek E, El-Shafey EM, Abo-Zenah H.

Cytokine. 2006 Aug;35(3-4):148-53. Epub 2006 Oct 5.

PMID:
17027280
8.

Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.

Robak E, Sysa-Jedrzejewska A, Dziankowska B, Torzecka D, Chojnowski K, Robak T.

Arch Immunol Ther Exp (Warsz). 1998;46(6):375-80.

PMID:
9883317
9.

[Proinflammatory cytokines in inactive lupus erythematosus patients].

Lesiak A, Sysa-Jedrzejowska A, Narbutt J, Lukamowicz J, Robak E, Wozniacka A.

Przegl Lek. 2005;62(9):838-42. Polish.

PMID:
16541713
10.

Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.

Sabry AA, Elbasyouni SR, Kalil AM, Abdel-Rahim M, Mohsen T, Sleem A.

Nephrology (Carlton). 2006 Aug;11(4):329-35.

PMID:
16889573
11.

Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.

Mangge H, Kenzian H, Gallistl S, Neuwirth G, Liebmann P, Kaulfersch W, Beaufort F, Muntean W, Schauenstein K.

Arthritis Rheum. 1995 Feb;38(2):211-20.

PMID:
7848311
12.

Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.

Gattorno M, Vignola S, Barbano G, Sormani MP, Sabatini F, Buoncompagni A, Picco P, Pistoia V.

J Rheumatol. 2000 Sep;27(9):2251-5.

PMID:
10990243
13.

Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.

Gattorno M, Picco P, Barbano G, Stalla F, Sormani MP, Buoncompagni A, Gusmano R, Borrone C, Pistoia V.

J Rheumatol. 1998 Feb;25(2):361-5.

PMID:
9489835
14.

Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.

Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.

Anticancer Res. 2001 Jul-Aug;21(4B):3053-9.

PMID:
11712810
15.

Cytokine concentration in serum of lupus erythematosus patients: the effect on acute phase response.

Lacki JK, Leszczynski P, Kelemen J, Müller W, Mackiewicz SH.

J Med. 1997;28(1-2):99-107.

PMID:
9249616
16.

Cytokines and adhesion molecules in renal vasculitis and lupus nephritis.

Tesar V, Masek Z, Rychlík I, Merta M, Bartůnková J, Stejskalová A, Zabka J, Janatková I, Fuciková T, Dostál C, Becvár R.

Nephrol Dial Transplant. 1998 Jul;13(7):1662-7.

PMID:
9681708
17.

Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.

Turan B, Gallati H, Erdi H, Gürler A, Michel BA, Villiger PM.

J Rheumatol. 1997 Jan;24(1):128-32.

PMID:
9002023
18.

Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.

Koller-Strametz J, Pacher R, Frey B, Kos T, Woloszczuk W, Stanek B.

J Heart Lung Transplant. 1998 Apr;17(4):356-62.

PMID:
9588580
20.

Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis.

Gattorno M, Picco P, Buoncompagni A, Stalla F, Facchetti P, Sormani MP, Pistoia V.

Ann Rheum Dis. 1996 Apr;55(4):243-7.

Supplemental Content

Support Center